Warner Chilcott plc (WCRX) Thursday announced the United States Food and Drug Administration or FDA approval of a new oral contraceptive, norethindrone acetate and ethinyl estradiol chewable tablets and ferrous fumarate tablets, for the prevention of pregnancy. The product does not currently have a brand name.
The new oral contraceptive which is indicated for use by women of reproductive age to prevent pregnancy, is expected to be commercially launched in early August 2013.
For comments and feedback: editorial@rttnews.com